Literature DB >> 6109286

Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.

D van Calker, M Müller, B Hamprecht.   

Abstract

Secretin stimulates the accumulation of cyclic AMP (half maximally stimulating concentration: 10-20 nM) in cultured mouse brain cells mainly consisting of glioblasts. Vasoactive intestinal peptide (VIP) is much less potent in raising the level of cyclic AMP in these cultures. The effect of secretin but not that of VIP is inhibited by secretin-(5-27), a synthetic antagonist of secretin. Stimulation of the adrenergic alpha-receptors and the adenosine A1-receptors present on the cells attenuates the increase in cyclic AMP evoked by secretin and VIP. Somatostatin at low concentrations inhibits the accumulation of cyclic AMP (half-maximally inhibitory concentration: 3 nM), in the absence or presence of secretin, VIP, or isoproterenol. The results suggest that secretin might regulate the concentration of cyclic AMP in brain and provoke the question of a possible involvement of glial cells in the action of peptide hormones in the brain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109286      PMCID: PMC350400          DOI: 10.1073/pnas.77.11.6907

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Immunohistochemical localization of somatostatin (growth hormone release-inhibiting factor) in the guinea pig brain.

Authors:  T Hökfelt; S Efendic; O Johansson; R Luft; A Arimura
Journal:  Brain Res       Date:  1974-11-08       Impact factor: 3.252

2.  Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures.

Authors:  J Booher; M Sensenbrenner
Journal:  Neurobiology       Date:  1972

3.  Regulation of glycerol phosphate dehydrogenase by hydrocortisone in dissociated rat cerebral cell cultures.

Authors:  G A Breen; J de Vellis
Journal:  Dev Biol       Date:  1974-12       Impact factor: 3.582

4.  The interaction of vasoactive intestinal polypeptide and secretin with liver-cell membranes.

Authors:  B Desbuquois
Journal:  Eur J Biochem       Date:  1974-08-01

5.  Maturation-stimulation effect of brain extract and dibutyryl cyclic AMP on dissociated embryonic brain cells in culture.

Authors:  R Lim; K Mitsunobu; W K Li
Journal:  Exp Cell Res       Date:  1973-04       Impact factor: 3.905

6.  Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes.

Authors:  B Desbuguois; M H Laudat; P Laudat
Journal:  Biochem Biophys Res Commun       Date:  1973-08-21       Impact factor: 3.575

7.  Morphological and biochemical alterations in foetal rat brain cells cultured in the presence of monobutyryl cyclic AMP.

Authors:  D L Shapiro
Journal:  Nature       Date:  1973-01-19       Impact factor: 49.962

8.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

9.  Effects of somatostatin and hypothalamic ventromedial lesions on GH release induced by morphine.

Authors:  J B Martin; J Audet; A Saunders
Journal:  Endocrinology       Date:  1975-04       Impact factor: 4.736

10.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

View more
  19 in total

1.  Neuropeptide Y, somatostatin, and cholecystokinin neurone preservation in anaplastic astrocytomas.

Authors:  S Przedborski; S Goldman; S N Schiffmann; G Vierendeels; M Depierreux; M Levivier; J Hildebrand; J J Vanderhaeghen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Multiple pertussis toxin substrates as candidates for regulatory G proteins of adenylate cyclase coupled to the somatostatin receptor in primary rat astrocytes.

Authors:  P J Gebicke-Haerter; A Seregi; S Wurster; A Schobert; C Allgaier; G Hertting
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

3.  A phosphoinositide-linked peptide response in astrocytes: evidence for regional heterogeneity.

Authors:  A J Cholewinski; M R Hanley; G P Wilkin
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

Review 4.  Primary astroglial cultures. A biochemical and functional evaluation.

Authors:  E Hansson
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

5.  Effects of secretin on content of PGE2 and 6-keto PGF1 alpha in gastric mucosa.

Authors:  T Mine; J Fujisaki; K Akimoto; S Yoshida; Y Hasegawa; E Ogata
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

6.  Somatostatin binding sites on rat diencephalic astrocytes. Light-microscopic study in vitro and in vivo.

Authors:  B Krisch; C Buchholz; R Mentlein
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

7.  Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.

Authors:  G Taton; M Delhaye; J C Camus; P de Neef; P Chatelain; P Robberecht; J Christophe
Journal:  Pflugers Arch       Date:  1981-09       Impact factor: 3.657

8.  Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.

Authors:  P J Magistretti; J H Morrison; W J Shoemaker; V Sapin; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Amino acid and monoamine transport in primary astroglial cultures from defined brain regions.

Authors:  E Hansson; P Eriksson; M Nilsson
Journal:  Neurochem Res       Date:  1985-10       Impact factor: 3.996

10.  Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity.

Authors:  B Gonzalez; P Leroux; M Lamacz; C Bodenant; R Balazs; H Vaudry
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.